Back to Results
First PageMeta Content
Biotechnology / Pharmacology / Asuragen / KRAS / BRAF / Biomarker / AKT1 / HRAS / Ras subfamily / Medicine / Biology / Oncogenes


Next Generation Sequencing ACCURATE DETECTION OF CLINICALLY ACTIONABLE MUTATIONS DISCOVER • DEVELOP • DIAGNOSE Targeted FFPE Sequencing to Identify Novel, Disease-Related Mutations
Add to Reading List

Document Date: 2013-10-08 13:04:35

Open Document

File Size: 1,15 MB

Share Result on Facebook

Company

Asuragen Inc. / Tests (LDTs) Asuragen / /

/

IndustryTerm

genomic and diagnostic services / clinical applications / genomic services / clinical testing services / diagnostic products / patient management / personalized healthcare climate / clinical solutions / /

MedicalCondition

genetic disease / disease / heterogenous tumor / /

/

Technology

genomics / bioinformatics / NGS technologies / drug development / /

SocialTag